{"id":12314,"date":"2026-04-28T07:44:09","date_gmt":"2026-04-28T07:44:09","guid":{"rendered":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/2026\/04\/28\/novartis-ceo-warns-reality-of-trumps-drug-pricing-policy-will-set-in-over-the-next-18-months-cnbc\/"},"modified":"2026-04-28T07:44:09","modified_gmt":"2026-04-28T07:44:09","slug":"novartis-ceo-warns-reality-of-trumps-drug-pricing-policy-will-set-in-over-the-next-18-months-cnbc","status":"publish","type":"post","link":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/2026\/04\/28\/novartis-ceo-warns-reality-of-trumps-drug-pricing-policy-will-set-in-over-the-next-18-months-cnbc\/","title":{"rendered":"Novartis CEO warns reality of Trump&#8217;s drug pricing policy will set in over &#8216;the next 18 months&#8217; &#8211; CNBC"},"content":{"rendered":"<div id=\"RegularArticle-ArticleBody-5\" data-module=\"ArticleBody\" data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\">\n<div>\n<p><span data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-1\"><a href=\"http:\/\/www.cnbc.com\/quotes\/NVS\/\">Novartis<\/a><span><span id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><\/span><\/span><\/span>&#8216; CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a &#8220;very difficult situation&#8221; and the reality will soon catch up with both drugmakers and patients.<\/p>\n<p>&#8220;The longer-term implications are significant,&#8221; CEO Vas Narasimhan told CNBC&#8217;s <a href=\"https:\/\/www.cnbc.com\/carolin-roth\/\">Carolin Roth<\/a>.<\/p>\n<p>Novartis is focused on getting European and Japanese governments to quickly change how they reward innovation, he said, adding that if this doesn&#8217;t happen, then novel medicines might see delayed entry into these markets and patients won&#8217;t have access to the drugs.<\/p>\n<p>&#8220;The reality of MFN is going to set in in the next 18 months.&#8221;<\/p>\n<\/div>\n<div id=\"Placeholder-ArticleBody-Video-108298118\" data-test=\"VideoPlaceHolder\" role=\"region\" tabindex=\"0\" data-vilynx-id=\"7000411087\" aria-labelledby=\"Placeholder-ArticleBody-Video-108298118\">\n<p><img decoding=\"async\" src=\"https:\/\/image.cnbcfm.com\/api\/v1\/image\/108298119-17773589601777358957-45562224600-1080pnbcnews.jpg?v=1777358959&#038;w=750&#038;h=422&#038;vtcrop=y\" alt=\"Novartis CEO: We knew these first two quarters would be bumpy\"><span><\/span><span><\/span><\/p>\n<\/div>\n<p><em><strong>This is breaking news. Please refresh for updates.<\/strong><\/em> <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Novartis&#8216; CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a &#8220;very difficult situation&#8221; and the reality will soon catch up with both drugmakers and patients. &#8220;The longer-term implications are significant,&#8221; CEO Vas Narasimhan told CNBC&#8217;s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":12315,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-12314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/posts\/12314","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/comments?post=12314"}],"version-history":[{"count":0,"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/posts\/12314\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/media\/12315"}],"wp:attachment":[{"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/media?parent=12314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/categories?post=12314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wpinitiate.com\/echo-test\/demo973e36f5\/wp-json\/wp\/v2\/tags?post=12314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}